| Literature DB >> 32222300 |
Anja Soldan1, Corinne Pettigrew2, Marilyn Albert2.
Abstract
The concept of cognitive reserve (CR) was proposed to account for the discrepancy between levels of brain pathologic process or damage and clinical and cognitive function. We provide a detailed review of prospective longitudinal studies that have investigated the interaction between CR and Alzheimer disease (AD) biomarkers on clinical and cognitive outcomes among individuals with normal cognition at baseline. Current evidence is consistent with the view that higher levels of CR are associated with a delay in the onset of symptoms of mild cognitive impairment and that there may be multiple pathways by which CR exerts its protective effects.Entities:
Keywords: Alzheimer disease; Amyloid; Atrophy; Biomarkers; Cognitive reserve; Mild cognitive impairment; Tau
Mesh:
Year: 2019 PMID: 32222300 PMCID: PMC7837205 DOI: 10.1016/j.cger.2019.11.006
Source DB: PubMed Journal: Clin Geriatr Med ISSN: 0749-0690 Impact factor: 3.076